Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2025-12-25 @ 9:29 PM
NCT ID: NCT02961751
Description: Ciprofloxacin has a well-established safety profile and has been prescribed to several millions of people in the US and worldwide as it was the CDC's recommended treatment regimen for uncomplicated gonorrhea from 1993 to 2007. Therefore, adverse event assessment was not required for this study.
Frequency Threshold: 0
Time Frame: Adverse events were not collected for this study.
Study: NCT02961751
Study Brief: Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Ciprofloxacin One dose of directly-observed ciprofloxacin 500 mg administered orally 0 None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):